The position of combined medical treatment in acromegaly
Arch. endocrinol. metab. (Online)
;
63(6): 646-652, Nov.-Dec. 2019.
Article
Dans Anglais
| LILACS
| ID: biblio-1055016
ABSTRACT
ABSTRACT Advances in combination medical treatment have offer new perspectives for acromegaly patients with persistent disease activity despite receiving the available medical monotherapies. The outcomes of combination medical treatment may reflect both additive and synergistic effects. This review focuses on combination medical treatment and its current position in acromegaly, based on clinical studies evaluating the efficacy and safety of combined medical treatment(s) and our own experiences with combination therapy. Arch Endocrinol Metab. 2019;63(6)646-52
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Somatostatine
/
Récepteur somatostatine
/
Agonistes de la dopamine
/
Hormone de croissance humaine
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Arch. endocrinol. metab. (Online)
Thème du journal:
Endocrinologie
/
Métabolisme
Année:
2019
Type:
Article
Pays d'affiliation:
Hongrie
Institution/Pays d'affiliation:
Erasmus University Medical Center Rotterdam/hungria
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS